Adjuvant @entity1161 in metastatic @entity1600 from XXXX .

@entity1161 @entity1 @entity1600 @entity320
PURPOSE: To analyze the outcome after adjuvant @entity1161 with standard fractionation regimen in metastatic @entity1600 ( @entity1600 ) from @entity320 . @entity1 AND METHODS: 86 successive @entity1 (57 @entity1 ) were treated for locally advanced @entity320 in our institution. 60 @entity1 (69%) underwent @entity1600 dissection followed by @entity1161 ( @entity1161 ), while 26 @entity1 (31%) had no radiotherapy. RESULTS: The median number of resected @entity1600 was 12 (1 to 36) with 2 metastases (1 to 28). Median survival after the first relapse was 31.8 months. Extracapsular extension was a significant prognostic factor for regional control (p = 0.019). Median total dose was 50 Gy (30 to 70 Gy). A standard fractionation regimen was used (2 Gy/fraction). Median number of fractions was 25 (10 to 44 fractions). @entity1 were treated with five fractions/week. @entity1 with extracapsular extension treated with surgery followed by @entity1161 (total dose >= 50 Gy) had a better regional control than @entity1 treated by surgery followed by @entity1161 with a total dose <50 Gy (80% vs. 35% at 5-year follow-up; p = 0.004). CONCLUSION: Adjuvant radiotherapy was able to increase regional control in targeted sub-population ( @entity1600 with extracapsular extension).
